The biotech agency 180 Life Sciences has rebranded as ETHZilla after launching a treasury in Ethereum (ETH) value $425 million. Due to this fact, shifting its focus to blockchain as a substitute of biotech. The initiative will see the corporate use Ethereum as a core treasury asset and an ordinary for on-chain monetary methods. ETHZilla Goals to Turn out to be Ethereum Treasury
The put up 180 Life Sciences To Launch $425M Ethereum Treasury, Rebrands to ETHZilla appeared first on CoinGape.